Evidence map›Paper›PMID 25678587›Full record

ArticleCardiovascular research2015

miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice.

Wen Ding, Jihe Li, Jayanti Singh, Razan Alif, Roberto I Vazquez-Padron, Samirah A Gomes, Joshua M Hare, Lina A Shehadeh

Erratum issuedOpen access · greenAbstract readComparative Study
In one paragraph

Article in Cardiovascular research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecular therapy. Nucleic acids · 2020
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. New incriminating evidence against IGF2.Translational cancer research · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Wen DingDepartment of Molecular and Cellular Pharmacology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA Interdisciplinary Stem Cell Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.
Jihe LiInterdisciplinary Stem Cell Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA Department of Medicine, Division of Cardiology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.
Jayanti SinghInterdisciplinary Stem Cell Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA Department of Medicine, Division of Cardiology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.
Razan AlifDepartment of Biochemistry, University of Miami, Coral Gables, FL 33136, USA.
Roberto I Vazquez-PadronDepartment of Surgery, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA Vascular Biology Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.
Samirah A GomesInterdisciplinary Stem Cell Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.
Joshua M HareInterdisciplinary Stem Cell Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA Department of Medicine, Division of Cardiology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA.
Lina A ShehadehInterdisciplinary Stem Cell Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA Department of Medicine, Division of Cardiology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA Vascular Biology Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA lshehadeh@med.miami.edu.
University of Miami · US

Funding

Cardioprotective Effect of Growth Hormone Releasing HormoneR01HL107110 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARE, JOSHUA M · 2011 to 2020
$5.9M
Cell Based Therapy for Non-Ischemic Dilated CardiomyopathyUM1HL113460 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARE, JOSHUA M · 2012 to 2018
$4.3M
Cellular Cardiomyoplasty for Chronic Heart FailureR01HL084275 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARE, JOSHUA M · 2007 to 2016
$3.8M
Stem Cells for Dilated CardiomyopathyR01HL110737 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARE, JOSHUA M · 2011 to 2015
$3.2M
Leukadherins as novel compounds for treating restenosisR01HL109582 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GUPTA, VINEET, VAZQUEZ PADRON, ROBERTO IRENARDO · 2012 to 2015
$1.7M
Vascular Progenitor Cells in Arteriovenous Fistula StenosisR01DK098511 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ANDREOPOULOS, FOTIOS MATTHAIOS, SALMAN, LOAY HATEM · 2013 to 2016
$1.5M
Mechanisms for miR-30e Regulated Atherogenic Pathways with AgeK01AG040468 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SHEHADEH, LINA A · 2012 to 2014
$365k
NHLBI NIH HHS R01HL084275NHLBI NIH HHS R01HL107110NHLBI NIH HHS R01 HL109582NHLBI NIH HHS R01HL109582NHLBI NIH HHS R01HL110737-01NHLBI NIH HHS UM1HL113460NIA NIH HHS K01 AG040468NIDDK NIH HHS R01 DK098511NIDDK NIH HHS R01DK098511
6 · The paper itself

Abstract

aimsActivation of an osteogenic transcriptional program contributes to the initiation of aortic calcification in atherosclerosis. The role of microRNAs in regulating aortic calcification is understudied. We tested the hypothesis that miR-30e regulates an osteogenic program in bone marrow-derived mesenchymal stem cells (MSCs), aortic smooth muscle cells (SMCs), and ApoE(-/-) mice. METHODS AND

resultsIn aortas of wild-type mice, we found that miR-30e is highly expressed in medial SMCs. In aortas of old ApoE(-/-) mice, we found that miR-30e transcripts are down-regulated in an inverse relation to the osteogenic markers Runx2, Opn, and Igf2. In vitro, miR-30e over-expression reduced the proliferation of MSCs and SMCs while increasing adipogenic differentiation of MSCs and smooth muscle differentiation of SMCs. In MSCs and SMCs over-expressing miR-30e, microarrays and qPCR showed repression of an osteogenic gene panel including Igf2. Inhibiting miR-30e in MSCs increased Igf2 transcripts. In SMCs, IGF2 recombinant protein rescued miR-30e-repressed osteogenic differentiation. Luciferase and mutagenesis assays showed binding of miR-30e to a novel and essential site at the 3'UTR of Igf2. In ApoE(-/-) mice, injections of antimiR-30e oligos increased Igf2 expression in the aortas and livers and significantly enhanced OPN protein expression and calcium deposition in aortic valves.

conclusionmiR-30e represses the osteogenic program in MSCs and SMCs by targeting IGF2 and drives their differentiation into adipogenic or smooth muscle lineage, respectively. Our data suggest that down-regulation of miR-30e in aortas with age and atherosclerosis triggers vascular calcification. The miR-30e pathway plays an important regulatory role in vascular diseases.

Indexed as

AgingAnimalsAortaApolipoproteins EBone Marrow CellsCalcinosisCell DifferentiationCells, CulturedDisease Models, AnimalDown-RegulationInsulin-Like Growth Factor IIMaleMesenchymal Stem CellsMiceMice, Inbred C57BLMice, KnockoutApolipoproteins EIGF2 protein, mouseInsulin-Like Growth Factor IIMicroRNAsMirn30d microRNA, mouseCalcificationMesenchymal stem cellsMicroRNA-30eOsteogenesisSmooth muscle cells

Identifiers

PMID25678587
PMCPMC4375408
OpenAlexW1991972761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.